Market revenue in 2023 | USD 18.2 million |
Market revenue in 2030 | USD 29.0 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Bioavailability & bioequivalence studies |
Fastest growing segment | Pharmacokinetics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test type |
Key market players worldwide | IQVIA Holdings Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Charles River Laboratories International Inc, Syneos Health, Intertek Group PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy bioanalytical testing services market will help companies and investors design strategic landscapes.
Bioavailability & bioequivalence studies was the largest segment with a revenue share of 35.71% in 2023. Horizon Databook has segmented the UK cell & gene therapy bioanalytical testing services market based on bioavailability & bioequivalence studies, pharmacokinetics, pharmacodynamics, other test type covering the revenue growth of each sub-segment from 2018 to 2030.
A key factor driving the market growth is the presence of an independent institute that focuses on therapeutics, as well as leading-edge expertise in cell and gene technologies, such as Stevenage Bioscience Catalyst and The Cell and Gene Therapy Catapult (CGT Catapult).
For example, CGT Catapult is an independent innovation and technology organization dedicated to trying to make a difference in the UK's cell and gene therapy companies. Furthermore, the UK is home to numerous prosperous businesses, top-notch academic institutions, and the CGT Catapult, which is wellpositioned to support market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the UK cell & gene therapy bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into UK cell & gene therapy bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account